Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
Copyright 2001 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2001
In Reply: As our analysis showed, most adults
who develop IPD have a vaccine indication according to current guidelines.1 Furthermore, most IPD among adults is due to serotypes
that are included in the PPV. Current vaccine recommendations also address
those people most likely to die from IPD. The burden of IPD in adults remains
high even though PPVs have been available for several decades.2
Improving vaccine coverage among adults with vaccine indications will reduce
disease burden. As the PPV has been shown to be safe and cost effective for
preventing IPD, use of the vaccine should be actively promoted.
Robinson KA, Whitney CG. Pneumococcal Vaccination in Adults—Reply. JAMA. 2001;286(2):166-167. doi:10.1001/jama.286.2.166